Cargando…

Restrictive cardiomyopathy: definition and diagnosis

Restrictive cardiomyopathy (RCM) is a heterogeneous group of diseases characterized by restrictive left ventricular pathophysiology, i.e. a rapid rise in ventricular pressure with only small increases in filling volume due to increased myocardial stiffness. More precisely, the defining feature of RC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapezzi, Claudio, Aimo, Alberto, Barison, Andrea, Emdin, Michele, Porcari, Aldostefano, Linhart, Ales, Keren, Andre, Merlo, Marco, Sinagra, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712030/ https://www.ncbi.nlm.nih.gov/pubmed/36269634 http://dx.doi.org/10.1093/eurheartj/ehac543

Ejemplares similares

Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
por: Aimo, Alberto, et al.
Publicado: (2022)

Exploring the possible link between myocarditis and mRNA COVID-19 vaccines
por: Sinagra, Gianfranco, et al.
Publicado: (2021)

Re-Definition of the Epidemiology of Cardiac Amyloidosis
por: Rossi, Maddalena, et al.
Publicado: (2022)

Value of the HFA‐PEFF and H(2)FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
por: Tomasoni, Daniela, et al.
Publicado: (2022)

New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy
por: Pio Loco detto Gava, Carola, et al.
Publicado: (2023)

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
por: Kandzari, David E., et al.
Publicado: (2022)

One-Year Risk of Myocarditis After COVID-19 Infection: A Systematic Review and Meta-analysis
por: Zuin, Marco, et al.
Publicado: (2023)

Editorial: Proceedings and predictions in cardiac amyloidosis: unsolved mysteries and challenges for the future
por: Porcari, Aldostefano, et al.
Publicado: (2023)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery
por: Porcari, Aldostefano, et al.
Publicado: (2021)

Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023)

Cardiac amyloidosis: do not forget to look for it
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Endomyocardial biopsy in the clinical context: current indications and challenging scenarios
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
por: Anderson, James J., et al.
Publicado: (2022)

Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2022)

Role of Imaging in Cardiomyopathies
por: Castiglione, Vincenzo, et al.
Publicado: (2023)

Functional Angioplasty: Definitions, Historical Overview, and Future Perspectives
por: Park, Hanbit, et al.
Publicado: (2021)

Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
por: Luu, Albert Z., et al.
Publicado: (2018)

Major Clinical Issues in Hypertrophic Cardiomyopathy
por: Lee, Hyun-Jung, et al.
Publicado: (2022)

Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination
por: Porcari, Aldostefano, et al.
Publicado: (2021)

Evolution of the term and definition of dysplasia of the hip – a review of the literature
por: Musielak, Bartosz, et al.
Publicado: (2015)

Translation of New and Emerging Therapies for Genetic Cardiomyopathies
por: Helms, Adam S., et al.
Publicado: (2021)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review
por: Shapiro, Adam J., et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation
por: Seok, Heeyoung, et al.
Publicado: (2021)

Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
por: Kim, Kyung-Hee, et al.
Publicado: (2021)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy
por: Porcari, Aldostefano, et al.
Publicado: (2022)

A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation
por: Nuzzi, Vincenzo, et al.
Publicado: (2023)

Psychosis in children: diagnosis and treatment
por: Courvoisie, Helen, et al.
Publicado: (2001)

Anti-SARS-CoV-2 vaccine-induced myocarditis – real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology
por: Sousa, José Pedro, et al.
Publicado: (2023)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Core symptoms of major depressive disorder: relevance to diagnosis and treatment
por: Kennedy, Sidney H.
Publicado: ( 200)

Novel aspects in diagnostic approach to respiratory patients: is it the time for a new semiotics?
por: Soldati, Gino, et al.
Publicado: (2017)

The impossible interviews—Sherlock Holmes interviews David Sackett: ‘how much can we trust the guidelines?’
por: Rapezzi, Claudio, et al.
Publicado: (2021)

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)

Final farewell to Claudio Rapezzi: observation, deduction and knowledge in medicine
por: Porcari, Aldostefano, et al.
Publicado: (2023)

From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
por: Crotti, Lia, et al.
Publicado: (2023)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
por: Fontana, Marianna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i3cpigpm74dgu2hi6muui3ltgi